Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

35 results about "Lactococcus cremoris" patented technology

Fresh and soft cheese and preparation method thereof

InactiveCN101715836ASuppress high blood pressureImprove the shortcomings of fermented lactic acidityCheese manufacturePasteurizationHigh pressure homogenization
The invention relates to a fresh and soft cheese and a preparation method thereof. After animal milk is pasteurized at high temperature or sterilized at ultra-high temperature and homogenized, a mixed lactobacillus fermenting agent containing lactococcus cremoris, lactobacillus helveticus and lactococcus lactis is added, the inoculum amount is 1% to 5%, a small amount of rennin is added, and the formed curdled milk is separated by heating so that the product has moderate acidity, smooth texture and daubing performance. The lactobacillus helveticus added in the cheese generates gramicidin containing angiotonase inhibiting factors during milk fermentation so that the fresh and soft cheese prepared from the lactobacillus helveticus has the function of hypertension prevention. By adopting the lactococcus lactis for mixed fermentation, the prominent defects of fermentation lactic acid are improved, and ketonic product different from common aldehydic fermentation milk products is produced. In addition, due to the adoption of high-temperature pasteurization and high-pressure homogenization, the preparation method changes the traditional low-temperature cheese pasteurizing and non-homogenizing method so as to promote the formation of smooth textures.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY +1

Preparation method of lactococcus lactis product expressing phenylalanine ammonia lyase

The invention belongs to the field of biological medicine, and relates to a preparation method of a lactococcus lactis product expressing phenylalanine ammonia lyase, and the method orderly comprises the following steps: 1) obtaining a gene which expresses phenylalanine ammonia lyase; 2) connecting the gene which expresses phenylalanine ammonia lyase with a expression vector which is suitable forlactococcus lactis transformation so as to form a recombinant expression vector; 3) transforming competent lactococcus lactis by the recombinant expression vector; 4) screening to obtain a lactococcus lactis strain which highly expresses phenylalanine ammonia lyase; 5) fermenting the lactococcus lactis and inducing the expression of phenylalanine ammonia lyase; 6) drying the obtained fermented strain; wherein the pH of the fermentation liquid is adjusted to be 6.0-6.5 before the induction of fermentation in step 5); the pH is adjusted to be 6.5-7.5 after the induction; the strain is continued to be cultured till the fermentation is finished. With the technical scheme of the invention, the living bacteria number of the obtained lactococcus lactis and the specific activity of phenylalanine ammonia lyase are greatly increased, wherein the former reaches up to above 1012 CFU / ml, and the later reaches up to above 80 U / g.
Owner:BEIJING TRI PRIME GENE PHARMA CO LTD

Making method for sour fermented fishes

The invention discloses a making method for sour fermented fishes. Freshwater fishes are taken as raw materials; scales, viscera and fish gills are removed; the fishes are cleaned with clean water andare drained off; the cleaned fishes undergo processes of salt application, fishy flavor removal and flavoring; a bacteria solution is added; and the flavored fishes are put at 10-15 DEG C and undergoes hermetic fermentation for 7-20 days to obtain the sour fermented fishes; bacteria of the bacteria solution are more than one of lactococcus lactis subsp. lactis, lactococcus lactis, lactobacillus plantarum and lactobacillus fermenti; and the sour fermented fishes and sour liquid obtained by fermentation are mixed-packaged to obtain sour fermented fish products. The invention provides a typicalfermented fish processing technique capable of realizing industrial production; the flavor and the texture of the products highlight product features of "sour fermented fishes" of minorities includingTujia minority, Dong minority, Miao nationality and the like; rapid fermentation production of a large number of fermented fishes can be realized, so that the deep processing rate and the comprehensive utilization rate of the freshwater fishes are improved; a foundation is laid for developing freshwater fish products which are safe, sanitary, convenient and nutrient; and the blank of industrial production of the sour fermented fishes in the market is filled.
Owner:DALIAN POLYTECHNIC UNIVERSITY

Preparation method of lactococcus lactis product for expressing phenylalanine ammonialyase

The invention belongs to the field of biomedicine, and relates to a preparation method of a lactococcus lactis product for expressing phenylalanine ammonialyase. The method sequentially comprises the following steps of: 1) acquiring genes for expressing the phenylalanine ammonialyase; 2) connecting the genes for expressing the phenylalanine ammonialyase and expression vectors suitable for transforming lactococcus lactis to form recombinant expression vectors; 3) transforming the recombinant expression vectors into competent lactococcus lactis; 4) screening lactococcus lactis strains for obtaining efficiently expressed phenylalanine ammonialyase; 5) fermenting the lactococcus lactis strains, and inducing the expressed phenylalanine ammonialyase; and 6) drying the strains obtained by fermentation, wherein the culture medium used in the fermentation of the step 5) is obtained by mixing an intermediate culture medium and an M17 broth culture medium in a volume ratio of 4:6-6:4; and regulating the pH value to be between 6.5 and 7.5. By adopting the technical scheme, the viable count of the obtained lactococcus lactis strains and the specific activity of the phenylalanine ammonialyase are greatly improved, wherein the viable count can reach over 10<12>CFU / ml, and the specific activity can reach over 80U / g.
Owner:BEIJING TRI PRIME GENE PHARMA CO LTD

Novel strains having effects of preventing or treating cancers

The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Lactococcus lactis GEN3033 strain of the present invention exhibits effects of directly inhibiting the proliferation of cancer cells and enhancing immunity, thereby having effects of preventing or treating cancers. In particular, the strain has an excellent anticancer effect by secreting metabolites having an anticancer effect while being established in the gut. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Lactococcus lactis GEN3033 strain of the present invention exhibits a better anticancer effect.
Owner:GENOME & CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products